AGÕæÈ˹ٷ½

STOCK TITAN

Corvel Corp SEC Filings

CRVL NASDAQ

Welcome to our dedicated page for Corvel SEC filings (Ticker: CRVL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking how CorVel Corporation converts advanced analytics into lower claim costs is vital, yet the company’s SEC paperwork is a maze of healthcare billing codes, captive insurance structures, and network contracting jargon. If you have ever searched “What does CorVel report in its 10-K?� or tried to locate a single footnote on network revenue in a 300-page filing, you know the challenge. Stock Titan resolves that frustration by layering AI-driven language models on top of every disclosure, turning raw documents into plain-English takeaways you can scan in seconds.

Open the CorVel annual report 10-K simplified to see segment profitability, risk factors, and how the CareMC platform scales. Need the latest CorVel quarterly earnings report 10-Q filing? We post it within minutes of hitting EDGAR and attach side-by-side KPI trends. Material updates, such as new managed-care contracts or Medicare set-aside rulings, appear under CorVel 8-K material events explained. Our dashboard also streams CorVel insider trading Form 4 transactions and CorVel executive stock transactions Form 4 so you can watch ownership shifts in real time and cross-check details in the CorVel proxy statement executive compensation section.

Whether you’re benchmarking medical cost containment peers or simply want CorVel SEC filings explained simply, Stock Titan’s tools help you:

  • Spot margin shifts with CorVel earnings report filing analysis.
  • Receive CorVel Form 4 insider transactions real-time on any device.
  • Compare claim volume trends across regions without reading every exhibit.
  • Understand complex reimbursement tables with AI-powered summaries.

All filings update automatically, and every paragraph links back to the source so analysts, insurers, and portfolio managers can trust the detail while saving hours. Understanding CorVel SEC documents with AI no longer requires a legal background—just open the page and let the insights surface.

Rhea-AI Summary

CorVel Corp (CRVL) Form 4 filing: Corstar Holdings Inc. reported a sale of 70,000 shares of CorVel common stock on 09/08/2025 at a price of $91.46 per share, leaving 18,742,108 shares beneficially owned following the transaction. The filing indicates the sale was made under a Rule 10b5-1 trading plan adopted May 28, 2025. The Form 4 is signed on behalf of the reporting entity and lists the reporting person as a director and 10% owner. The transaction is recorded as a direct disposition of common stock and no derivative transactions are reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Brandon O'Brien, identified as Chief Financial Officer of CorVel Corp (CRVL), reported a sale of company stock on 09/08/2025. The Form 4 shows 1,764 shares were sold at a price of $91.5367 per share, leaving 8,948 shares beneficially owned following the transaction. The filing was submitted on behalf of Mr. O'Brien by Sharon O'Connor on 09/10/2025. The disposition is reported as a direct holding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Corvel Corp (CRVL) Form 4: Corstar Holdings, Inc., filed by Jeffrey Michael as reporting person, reported a sale of 40,000 shares of Corvel common stock on 09/02/2025 at a reported price of $88.848 per share. After the sale, the reporting person beneficially owned 18,812,108 shares. The filing indicates the reporter is a director and the Form 4 was filed by one reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Summary

Form 144 notice discloses a proposed sale of 70,000 shares of common stock through UBS Financial Services on 09/08/2025 with an aggregate market value of $6,402,200.00. The filing reports 51,312,748 shares outstanding for the class. The shares were acquired as founders' shares on 05/01/1991. The filer also reported a sale within the past three months of 40,000 common shares on 09/02/2025 for gross proceeds of $3,553,923.00. The form includes the standard seller representation that no material nonpublic information is known to the seller.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

CorVel Corporation insider filing discloses a proposed sale of 1,764 common shares through Morgan Stanley Smith Barney LLC on 09/08/2025, with an aggregate market value of $161,470.74. The filing reports the company's outstanding common shares as 51,312,748, placing the proposed sale at a very small fraction of total shares.

The securities were acquired by exercise of options: 591 shares on 08/01/2024 and 1,173 shares on 01/02/2024, both paid in cash. The filer, identified as Brandon T O'Brien, also sold 3,957 shares on 06/09/2025 for $429,162.77. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

CorVel Corp (CRVL) Form 144 notice: A holder intends to sell 40,000 shares of common stock through UBS Financial Services on the NASDAQ, with an aggregate market value reported as $3,555,773.00 and an approximate sale date of 09/02/2025. The shares were acquired as Founders Shares from the issuer on 05/01/1991 and the filer reports no securities sold in the past three months. The notice includes the standard representation that the seller does not possess undisclosed material adverse information. The filing provides broker details and basic transaction disclosure but no forward guidance, financial results, or additional context about the holder.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Brandon O'Brien, Chief Financial Officer and Director of CorVel Corp (CRVL), reported agift disposition of 1,120 shares on 08/27/2025. The Form 4 shows the transaction coded G(1) with a price of $0.0 and an explanation stating the shares were gifted to "O'Brien Family Fund - DAFgiving360." After the reported disposition, Mr. O'Brien beneficially owned 10,712 shares. The filing lists the reporting persons address in Fort Worth, TX, and the Form is signed/submitted on 08/28/2025 by Sharon OConnor on behalf of Brandon OBrien.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Brandon O'Brien, Chief Financial Officer of CorVel Corp (CRVL), reported option exercise and related share transactions dated 08/22/2025. He exercised a non-qualified stock option to acquire 1,200 shares at an exercise price of $49.63, resulting in ownership of 1,200 underlying shares from that option. Concurrently, two sale transactions (codes F) show dispositions of 658 shares at $90.45 and 514 shares at $92.64. Following the reported transactions his reported beneficial ownership changed from 13,004 to 11,832 shares. The filing notes some shares were delivered to satisfy the option exercise price and/or tax liability and that the option vests 25% after one year with the remainder vesting monthly over three years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Maxim Shishin, Chief Information Officer of CorVel Corp (CRVL), reported option exercise and share sale transactions on 08/20/2025. He exercised 12,000 non-qualified stock options with an exercise price of $29.23 that are exercisable by 11/05/2025, resulting in ownership of 12,000 underlying shares from that exercise. On the same date he sold 12,000 shares at $89.1647 per share. After these transactions, his reported beneficial ownership in common stock was 7,050 shares and he beneficially owned 18,000 non-qualified stock options. The option vesting is tied to performance criteria related to earnings growth, per the filer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Summary

Form 144 notice for CorVel Corporation (CRVL): An insider has notified intent to sell 12,000 shares of Common stock through Morgan Stanley Smith Barney LLC on NASDAQ with an approximate aggregate market value of $1,069,975.20 based on the filing. The filing reports 51,312,748 shares outstanding for the issuer.

The filing shows the 12,000 shares were acquired on 08/20/2025 via stock option exercise and payment was made in cash on 08/20/2025. The filer also sold 2,400 shares on 06/09/2025 for gross proceeds of $259,416.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of Corvel (CRVL)?

The current stock price of Corvel (CRVL) is $85.65 as of September 10, 2025.

What is the market cap of Corvel (CRVL)?

The market cap of Corvel (CRVL) is approximately 4.6B.
Corvel Corp

NASDAQ:CRVL

CRVL Rankings

CRVL Stock Data

4.64B
28.75M
43.97%
53.79%
1.3%
Insurance Brokers
Insurance Agents, Brokers & Service
United States
IRVINE